14.09.2015 15:00:28

A 'Medical-Grade' Motion Sensor from STMicroelectronics Jumpstarts Creation of New Implantable Applications

Geneva, September 14, 2015 - STMicroelectronics (NYSE: STM), a global semiconductor leader serving customers across the spectrum of electronics applications, has introduced the MIS2DH, an ultra-low-power 3-axis accelerometer specifically designed for medical applications, including implantable devices classified by U.S. Food and Drug Administration (FDA) as Class III. ST has many years of experience in developing custom motion sensors for leading medical-equipment manufacturers and the MIS2DH distils this expertise into an off-the-shelf solution that can enable functions such as activity monitoring and posture sensing to be included in a wide range of medical applications.

Implantable medical devices such as cardiac pacemakers, ICDs (Implantable Cardioverter Defibrillator), and neurostimulators have been successfully used for many years to prolong the lives of patients with heart problems or to make life better for people with chronic pain conditions.  Today, there is a growing interest in the medical world in exploring how new implantable devices could help treat other chronic problems such as high blood pressure, epilepsy, and tremor-related conditions. For most of these applications, an embedded accelerometer capable of measuring the activity and posture of the patient is important to manage the stimulus delivered by the implantable device and therefore to improve the effectiveness of the treatment and the wellbeing of the patient.

Till now, a major obstacle for SMEs (Small and Medium Enterprises) wanting to develop innovative new medical devices has been the high costs associated with custom-designed sensors and obtaining FDA certification. The MIS2DH addresses this problem by combining a 3-axis mechanical element and an integrated electronic circuit in a single package, along with a set of collaterals required by customers seeking FDA Class III approval:

  • Dedicated Manufacturing and Testing flow, including additional checks, screening and process control;
  • Guaranteed retention of production records for more than 10 years;
  • Product-change management and notification aligned with medical standards;
  • Each batch is shipped with a Certificate of Conformity (CoC);
  • Long-term longevity commitment.

The MIS2DH accelerometer has been developed and produced in full compliance with the rules of ST's medical domain, a self-regulation that ST adopted in 2012 to secure the development and manufacturing flow for products intended for use in sensitive medical applications.

"Medical researchers and electronics technology experts from companies of all sizes are interested in exploring new ways in which implantable devices could help enhance or prolong the life of people with chronic conditions, which will be an increasingly pressing problem with the world's ageing population," said Anton Hofmeister, General Manager of ST's Custom MEMS Division. "By combining our world-leading expertise in motion-sensing with a robust set of procedures for developing, manufacturing, and testing devices aimed at applications that meet the most stringent medical regulatory requirements, ST is contributing to important progress in this field by significantly lowering the cost and time-to-market barriers."

  

Key technical features of the MIS2DH include:

  • 3-axis accelerometer;
  • ultra-small size (2x2x1mm3);
  • ultra-low power consumption (down to 2uA in low-power mode);
  • ±2g/±4g/±8g/±16g selectable full-scale;
  • 8-, 10- and 12-bit operating modes;
  • 1Hz - 5KHz output data rate;
  • FIFO buffer and programmable interrupt to minimize system power consumption;
  • I2C/SPI digital outputs;
  • 1.71 -3.6V operating voltage.

 

The MIS2DH is available now in volume. Please contact your ST sales office for pricing options and sample requests.

 

About STMicroelectronics

ST is a global semiconductor leader delivering intelligent and energy-efficient products and solutions that power the electronics at the heart of everyday life. ST's products are found everywhere today, and together with our customers, we are enabling smarter driving and smarter factories, cities and homes, along with the next generation of mobile and Internet of Things devices. By getting more from technology to get more from life, ST stands for life.augmented.

In 2014, the Company's net revenues were $7.40 billion, serving more than 100,000 customers worldwide. Further information can be found at www.st.com.

 

For Press Information Contact:

STMicroelectronics
Michael Markowitz
Director Technical Media Relations
+1 781 591 0354
michael.markowitz@st.com




This announcement is distributed by Nasdaq OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: STMicroelectronics via Globenewswire

HUG#1951817

Analysen zu STMicroelectronics N.V.mehr Analysen

09.12.24 STMicroelectronics Neutral JP Morgan Chase & Co.
28.11.24 STMicroelectronics Outperform Bernstein Research
22.11.24 STMicroelectronics Buy UBS AG
21.11.24 STMicroelectronics Buy Deutsche Bank AG
21.11.24 STMicroelectronics Neutral Goldman Sachs Group Inc.
Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

STMicroelectronics N.V. 25,05 -0,60% STMicroelectronics N.V.